Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

Share Price is delayed by 15 minutes
Get Live Data
20.00    0.00 (0.00%)
Bid:
19.00
Ask:
21.00
Spread: 2.00 (10.526%)
Market Cap: £43.80m
STCM Live PriceLast checked at - London Stock Exchange

Intraday Steppe Cement Share Chart

Director's Dealing

6 Aug 2024 08:21

RNS Number : 3439Z
Steppe Cement Limited
06 August 2024
 

6 August 2024

Steppe Cement Limited

("Steppe Cement" or the "Company")

Director's Dealing

Steppe Cement Limited announces that is has been notified that the family of the Company's Chief Executive Officer, Javier del Ser Pérez, has purchased 300,000 ordinary shares of nil par value each in the capital of the Company ("Ordinary Shares"), at a price of 13.8125 pence per share, via Portola Group Limited.

Accordingly, the family of Javier del Ser Pérez is now interested in 19,503,115 Ordinary Shares, representing approximately 8.91% of the Company's existing issued share capital.

 

For further information, please contact:

Steppe Cement Limited

www.steppecement.com

Javier del Ser Pérez, Chief Executive Officer

Tel: +(603) 2166 0361

Strand Hanson Limited (Nominated & Financial Adviser and Broker)

www.strandhanson.co.uk

James Spinney / Robert Collins / Ritchie Balmer

Tel: +44 20 7409 3494

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended by virtue of the Market Abuse (Amendment) (EU Exit) Regulations 2019.

PDMR Notification Form:

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Javier del Ser Pérez

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Steppe Cement Limited

b)

LEI

2138006TDVGH5T3U4Z46

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of nil par value each in the share capital of Steppe Cement Limited

Identification code

MYA004433001

b)

Nature of the Transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

13.8125 pence

300,000

d)

Aggregated information

Aggregated volume Price

300,000 shares at 13.8125 pence per share

e)

Date of the transaction

5 August 2024

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDQLBBZVLFBBD
Date   Source Headline
7th May 20097:00 amRNSUnderwritten Share Offer Results
24th Apr 20097:00 amRNSAnnual Report
14th Apr 200910:00 amRNSUnderwritten Offer of Shares
14th Apr 20097:31 amRNSPreliminary Results Update
16th Feb 20097:50 amRNSPreliminary Results
8th Jan 20097:02 amRNSDirector Shareholding
6th Jan 20097:00 amRNSHolding(s) in Company
19th Dec 20087:00 amRNSDirector Appointment
29th Oct 20088:00 amRNSSuccessful Commissioning of Line 6
17th Oct 20088:02 amRNSDirector Shareholding
17th Oct 20087:00 amRNSRefinancing of Credit Line
5th Sep 20089:01 amRNSInterim Results - Replacement
5th Sep 20088:16 amRNSInterim Results
19th May 20087:00 amRNSResult of AGM
16th May 20087:00 amRNSResignation of Director
6th May 20087:01 amRNSHolding(s) in Company
21st Apr 20081:55 pmRNSAnnual Report and Accounts
16th Apr 20087:00 amRNSFinal Results
21st Dec 20077:00 amRNSDirector/PDMR Shareholding
22nd Nov 20077:01 amRNSDirector/PDMR Shareholding
7th Sep 20077:00 amRNSCorrection to Interim Results
5th Sep 200711:46 amRNSInterim Results
24th Aug 20077:00 amRNSHolding(s) in Company
20th Aug 20078:22 amRNSAIM Rule 26 Information
20th Aug 20078:13 amRNSHolding(s) in Company
7th Aug 20077:00 amRNSNew Significant Shareholder
16th Jul 20079:11 amRNSHolding(s) in Company
5th Jul 20078:01 amRNSDirector/PDMR Shareholding
2nd Jul 200710:05 amRNSExtension to Credit Lines
25th Jun 20077:45 amRNSUpdate on Trading Position
25th May 20078:09 amRNSResult of AGM
21st May 20078:53 amRNSAnnual Report and Accounts
10th May 20078:39 amRNSHolding(s) in Company
8th May 20078:24 amRNSFinal Results
11th Apr 20077:00 amRNSDirectorate Change
5th Sep 20068:01 amRNSInterim Results
12th May 20067:55 amRNSSale of Shares
4th May 20067:00 amRNSDirector Appointment
3rd May 20067:00 amRNSDirector/PDMR Shareholding
2nd May 20067:00 amRNSHolding(s) in Company
26th Apr 20067:01 amRNSShareholder Transactions
26th Apr 20067:00 amRNSProposed Board Changes
13th Apr 200612:27 pmRNSAnnual Report and Accounts
3rd Apr 200611:18 amRNSFinal Results
2nd Mar 20067:47 amRNSFrthr re Production Expansion
23rd Feb 20067:00 amRNSHolding(s) in Company
2nd Feb 20067:00 amRNSDirector/PDMR Shareholding
1st Feb 20067:00 amRNSHolding(s) in Company
31st Jan 20067:23 amRNSDirector/PDMR Shareholding
30th Jan 20067:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.